Wim Weyenberg

1.0k total citations
28 papers, 796 citations indexed

About

Wim Weyenberg is a scholar working on Pharmaceutical Science, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wim Weyenberg has authored 28 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmaceutical Science, 14 papers in Public Health, Environmental and Occupational Health and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wim Weyenberg's work include Advanced Drug Delivery Systems (14 papers), Ocular Surface and Contact Lens (11 papers) and Corneal Surgery and Treatments (5 papers). Wim Weyenberg is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Ocular Surface and Contact Lens (11 papers) and Corneal Surgery and Treatments (5 papers). Wim Weyenberg collaborates with scholars based in Belgium, United States and Türkiye. Wim Weyenberg's co-authors include Andreas Ludwig, A. Ludwig, Jo Vandervoort, M. Hornof, Andreas Bernkop‐Schnürch, Louis Maes, An Matheeussen, A. Vermeire, Paul Cos and Jean Paul Remon and has published in prestigious journals such as Nature Reviews Drug Discovery, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Wim Weyenberg

27 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wim Weyenberg Belgium 15 442 237 163 148 90 28 796
Shilpa Kakkar India 11 518 1.2× 308 1.3× 137 0.8× 86 0.6× 62 0.7× 11 857
Narendra Kumar Jain India 15 223 0.5× 220 0.9× 167 1.0× 175 1.2× 66 0.7× 38 935
A. Ludwig Belgium 17 624 1.4× 293 1.2× 212 1.3× 322 2.2× 106 1.2× 41 1.2k
Esra Baloğlu Türkiye 15 547 1.2× 128 0.5× 80 0.5× 141 1.0× 67 0.7× 27 896
Zeynep Ay Şenyiğit Türkiye 13 510 1.2× 124 0.5× 118 0.7× 251 1.7× 79 0.9× 33 1.0k
Sinem Yaprak Karavana Türkiye 18 700 1.6× 147 0.6× 119 0.7× 223 1.5× 99 1.1× 52 1.2k
A Woolfson United Kingdom 7 491 1.1× 104 0.4× 121 0.7× 119 0.8× 51 0.6× 10 823
Hafiz Shoaib Sarwar Pakistan 17 396 0.9× 125 0.5× 176 1.1× 262 1.8× 75 0.8× 37 935
Sambhaji S. Pisal India 16 237 0.5× 67 0.3× 162 1.0× 107 0.7× 82 0.9× 31 756
José Luis Vila Jato Spain 10 488 1.1× 72 0.3× 231 1.4× 192 1.3× 56 0.6× 24 748

Countries citing papers authored by Wim Weyenberg

Since Specialization
Citations

This map shows the geographic impact of Wim Weyenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wim Weyenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wim Weyenberg more than expected).

Fields of papers citing papers by Wim Weyenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wim Weyenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wim Weyenberg. The network helps show where Wim Weyenberg may publish in the future.

Co-authorship network of co-authors of Wim Weyenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Wim Weyenberg. A scholar is included among the top collaborators of Wim Weyenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wim Weyenberg. Wim Weyenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weyenberg, Wim, et al.. (2025). Twelve-month efficacy of carboxymethyl-chitosan in refractory knee osteoarthritis: A randomized controlled trial (PIONEER). Osteoarthritis and Cartilage Open. 7(2). 100605–100605. 1 indexed citations
2.
3.
4.
Carleer, Robert, et al.. (2014). Development and characterization of mucoadhesive chitosan films for ophthalmic delivery of cyclosporine A. International Journal of Pharmaceutics. 472(1-2). 10–19. 67 indexed citations
5.
Weyenberg, Wim, et al.. (2012). Full factorial design, physicochemical characterisation and biological assessment of cyclosporine A loaded cationic nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 82(1). 27–35. 38 indexed citations
6.
Vermeersch, M, An Matheeussen, Jo Vandervoort, et al.. (2011). PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: Factor influence study and in vitro efficacy evaluation. International Journal of Pharmaceutics. 420(1). 122–132. 48 indexed citations
7.
Vandervoort, Jo, et al.. (2011). Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition onβ-aescin encapsulation. Journal of Microencapsulation. 29(2). 115–125. 5 indexed citations
8.
Vermeersch, M, Roosmarijn E. Vandenbroucke, An Matheeussen, et al.. (2011). Intracellular drug delivery inLeishmania-infected macrophages: Evaluation of saponin-loaded PLGA nanoparticles. Journal of drug targeting. 20(2). 142–154. 26 indexed citations
9.
Weyenberg, Wim, et al.. (2010). Nanosuspensions of chemically modified saponins: Reduction of hemolytic side effects and potential tool in drug targeting strategy. Journal of Controlled Release. 148(1). e122–e123. 1 indexed citations
10.
Weyenberg, Wim, et al.. (2010). The effect of HPβCD on Cyclosporine A in-vitro release from PLGA nanoparticles. Journal of Controlled Release. 148(1). e40–e41. 4 indexed citations
11.
Weyenberg, Wim, Els Adriaens, Valentijn Vergote, et al.. (2010). In vitro evaluation of gentamicin- and vancomycin-containing minitablets as a replacement for fortified eye drops. Drug Development and Industrial Pharmacy. 36(11). 1259–1270. 25 indexed citations
12.
Weyenberg, Wim, et al.. (2007). Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. International Journal of Pharmaceutics. 337(1-2). 291–298. 82 indexed citations
13.
Gasthuys, Frank, Chris Vervaet, Wim Weyenberg, et al.. (2007). Evaluation of thein vivobehaviour of gentamicin sulphate ocular mini‐tablets in ponies. Journal of Veterinary Pharmacology and Therapeutics. 30(5). 470–476. 5 indexed citations
14.
Weyenberg, Wim, et al.. (2005). Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol–starch components. European Journal of Pharmaceutics and Biopharmaceutics. 62(2). 202–209. 17 indexed citations
15.
Weyenberg, Wim, A. Vermeire, Jo Vandervoort, Jean Paul Remon, & Andreas Ludwig. (2005). Effects of roller compaction settings on the preparation of bioadhesive granules and ocular minitablets. European Journal of Pharmaceutics and Biopharmaceutics. 59(3). 527–536. 34 indexed citations
16.
Dillen, Kathleen, Wim Weyenberg, Jo Vandervoort, & Andreas Ludwig. (2004). The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 58(3). 539–549. 35 indexed citations
17.
Weyenberg, Wim, et al.. (2004). Rheological evaluation of the influence of sterilisation on ocular gels using an experimental design.. PubMed. 59(2). 121–5. 6 indexed citations
18.
Hornof, M., Wim Weyenberg, Andreas Ludwig, & Andreas Bernkop‐Schnürch. (2003). Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. Journal of Controlled Release. 89(3). 419–428. 125 indexed citations
19.
Weyenberg, Wim, A. Vermeire, J.P. Remon, & A. Ludwig. (2003). Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces. Journal of Controlled Release. 89(2). 329–340. 27 indexed citations
20.
Weyenberg, Wim & A. Ludwig. (2002). In vitro assessment of the interaction mechanisms between mucin and a cationic cellulosic derivative by rheological methods using an experimental design.. PubMed. 57(9). 628–31. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shilpa Kakkar Breakdown of academic impact, for papers by Narendra Kumar Jain Breakdown of academic impact, for papers by A. Ludwig Breakdown of academic impact, for papers by Esra Baloğlu Breakdown of academic impact, for papers by Zeynep Ay Şenyiğit Breakdown of academic impact, for papers by Sinem Yaprak Karavana Breakdown of academic impact, for papers by A Woolfson Breakdown of academic impact, for papers by Hafiz Shoaib Sarwar Breakdown of academic impact, for papers by Sambhaji S. Pisal Breakdown of academic impact, for papers by José Luis Vila Jato
Rankless by CCL
2026